Multi-omics reveals the DR5-FXR-CHPT1 axis governs hepatocyte pyroptosis via glycerophospholipid remodeling after major partial hepatectomy in male mice
Abstract
Severe liver injury following major partial hepatectomy (PHx) carries high mortality, yet the mechanisms driving irreversible cell death remain poorly understood. Here we show that aberrant lipid metabolism drives inflammatory cell death in the remaining liver tissue. Integrating data from male mouse models and human tissues, we found that death receptor 5 (DR5) acts as a critical regulator. Mechanistically, DR5 impedes the nuclear entry of the Farnesoid X Receptor (FXR), repressing the production of phosphatidylcholine (PC), an essential structural lipid. This lipid deficiency compromises the integrity of cellular membranes, causing severe stress and lethal pyroptosis. Restoring this pathway via DR5 suppression, FXR activation, or PC supplementation significantly alleviated post-surgical liver injury. Overall, we uncover a non-canonical metabolic function of DR5 that disrupts cellular homeostasis. These findings suggest that modulating this metabolic pathway may offer potential avenues for investigating future management strategies for small-for-size syndrome (SFSS) and post-hepatectomy liver failure (PHLF).
Related
- Potential Physiological Convergence Between GLP-1 Receptor Signaling and Hepatocyte TAZ in Metabolic Liver Disease: From Metabolic Homeostasis to Fibrotic Remodeling.
- Hepatocyte-derived selenoprotein P contributes to pressure overload–induced cardiac remodeling
- Single-Cell Transcriptomic Analysis Reveals Distinct Pathogenic Subtypes in Hepatocyte- and Cholangiocyte-Directed Autoimmune Liver Injury
- Graph attention network‐driven single‐cell omics analysis reveals how B4GALNT1‐mediated glycosylation remodelling of the ferroptosis–pyroptosis network promotes drug resistance in hepatocellular carcinoma
- Re-Du-Ning Alleviates Airway-Intestinal Inflammation of COPD Rats by Regulating Glycerophospholipid Metabolism and Modulating Gut Microbiome
BibTeX
@article{tang2026multiomics,
title = {{Multi-omics reveals the DR5-FXR-CHPT1 axis governs hepatocyte pyroptosis via glycerophospholipid remodeling after major partial hepatectomy in male mice}},
author = {Yongsheng Tang and Xu Lu and Xi Luo and Qinghai Lian and Yingqiu Song and Manqiu Kang and Zihan Qiao and Zhihua Rao and Linsen Ye and Zenan Yuan and Changchang Jia and Hua Li},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78113-8},
url = {https://www.nature.com/articles/s41467-026-78113-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Multi-omics reveals the DR5-FXR-CHPT1 axis governs hepatocyte pyroptosis via glycerophospholipid remodeling after major partial hepatectomy in male mice
AU - Yongsheng Tang
AU - Xu Lu
AU - Xi Luo
AU - Qinghai Lian
AU - Yingqiu Song
AU - Manqiu Kang
AU - Zihan Qiao
AU - Zhihua Rao
AU - Linsen Ye
AU - Zenan Yuan
AU - Changchang Jia
AU - Hua Li
PY - 2026
DA - 2026/10/07
JO - Nature Communications
DO - 10.1038/s41467-026-78113-8
UR - https://www.nature.com/articles/s41467-026-78113-8
AB - Severe liver injury following major partial hepatectomy (PHx) carries high mortality, yet the mechanisms driving irreversible cell death remain poorly understood. Here we show that aberrant lipid metabolism drives inflammatory cell death in the remaining liver tissue. Integrating data from male mouse models and human tissues, we found that death receptor 5 (DR5) acts as a critical regulator. Mechanistically, DR5 impedes the nuclear entry of the Farnesoid X Receptor (FXR), repressing the production of phosphatidylcholine (PC), an essential structural lipid. This lipid deficiency compromises the integrity of cellular membranes, causing severe stress and lethal pyroptosis. Restoring this pathway via DR5 suppression, FXR activation, or PC supplementation significantly alleviated post-surgical liver injury. Overall, we uncover a non-canonical metabolic function of DR5 that disrupts cellular homeostasis. These findings suggest that modulating this metabolic pathway may offer potential avenues for investigating future management strategies for small-for-size syndrome (SFSS) and post-hepatectomy liver failure (PHLF).
SN - 2041-1723
ER -